Tag:
Cangene Biopharma
Latest Headlines
Latest Headlines
Spectrum sues Cangene for breach of contract
Irvine, California-based Spectrum Pharmaceuticals is suing Cangene Biopharma in the U.S. District Court in Baltimore for allegedly breaching a 2008 contract to make Fusilev, an injectable cancer
